Bradley Foster & Sargent
MDLN icon

Bradley Foster & Sargent’s Medline Inc MDLN Stock Holding History

Bradley Foster & Sargent’s Portfolio MDLN Stock Details MDLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.2M Buy
511,274
+121,817
+31% +$4.91M 0.29% 76
2026
Q1 		$17.3M Buy
+389,457
New +$17.2M 0.27% 76

Other funds holding MDLN

Carlyle Group
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $39B AUM 18.55% 1-Year Est. Return
HFCIX
H&F Corporate Investors X San Francisco, California $2.8B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Lone Pine Capital
Lone Pine Capital Greenwich, Connecticut $16.4B AUM 99.7% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Bradley Foster & Sargent's MDLN Position: Q2 2026 in Review

Bradley Foster & Sargent increased its Medline Inc (MDLN) stake by 31% in Q2 2026, buying an estimated $4.91M and bringing the position to 511,274 shares worth $20.2M. The position accounts for 0.29% of the portfolio, ranked #76.

Bradley Foster & Sargent first reported a position in MDLN in Q1 2026 and has held it in 2 quarters since. 409 funds tracked by Wall St. Rank hold MDLN as of Q2 2026.

  • Bradley Foster & Sargent held 511,274 shares of Medline Inc worth $20.2M as of Q2 2026.
  • Bradley Foster & Sargent bought 121,817 Medline Inc shares in Q2 2026, an estimated $4.91M.
  • Medline Inc made up 0.29% of Bradley Foster & Sargent's portfolio in Q2 2026, its #76 holding.
  • Bradley Foster & Sargent first reported a position in Medline Inc in Q1 2026 and has held it in 2 quarters since.
  • 409 funds tracked by Wall St. Rank held Medline Inc as of Q2 2026.

Based on Bradley Foster & Sargent's 13F filing for Q2 2026, filed 14 Aug 2026.